- Home
- / APEIRON Biologics
APEIRON Biologics
APEIRON Biologics Summary
Company Summary
- Overview
- APEIRON Biologics is a biotech company focused on the discovery and development of cancer immunotherapies. Its product APN311 is an autologous cellular therapy to enhance immune reactivity via an intracellular immune master checkpoint. APEIRON's solution is developed for the treatment of pediatric neuroblastoma patients.
- Type
- Private
- Status
- Active
- Founded
- 2005
- HQ
- Wien, AT | view all locations
- Cybersecurity rating
Table of Contents
Key People
Andreas Stadler, Director Finance
Romana Gugenberger, Chief Medical & Scientific Officer (CMSO)
Andreas Gerber, Chief Operating Officer (COO)
